MedLit Blitz, Mark2Curathon Results and More

Mark2Curathon Results Sorry for the delay, the Mark2Curathon results are finally in! During the Mark2Cure portion of MedLit Blitz, we had 34 participants contribute over 16,000 annotations. Because both the entity recognition and the relationship extraction tasks are very different from Cochrane's screening task, we had to take some additional considerations when tallying the results. For the...
read more

The Mark2Curathon starts now!

Our anniversary celebration with Cochrane Crowd is well under way. #MedLitBlitz started with a webinar on Monday, and was followed by the Cochrane screening challenge from Tuesday to Wednesday. During that challenge, over 100 MedLit Blitzers screened 29,494 citations--over nine THOUSAND more than the initial goal of 20,000! But the celebrations aren't over yet. It's now time for the...
read more

Webinar, Mark2Curathon, and more

It’s citizen science season and we’re in the thick of it! First off, welcome new users! If you found us from the latest SciStarter campaign, feel free ping us on twitter to let us know so we can pass our thanks to the @SciStarter team! We’re very excited to be featured as part of SciStarter’s recent focus/feature on biomedical citizen science! Note, if you complete your SciStarter profile this...
read more

Celebrating the application of citizen science towards biomedical literature

Upcoming event — Med Lit Blitz! Extracting information from biomedical literature is a huge problem that many researchers are trying to solve computationally. Mark2Cure approaches the biomedical literature problem with citizen science in hopes of enhancing computational methods. Happily, we are no longer alone in this regard! In fact, a year after Mark2Cure officially launched, another citizen...
read more

New Entity Recognition Mission Available

Pilocarpine is a drug that was frequently identified by our Mark2Cure citizen scientists and volunteers in the previous sets of biomedical literature. It was often found in the context of seizures or tears—both of which are symptoms associated with NGLY1 deficiency. In humans, pilocarpine is used to pre-operatively treat some forms of glaucoma, and to treat the dry eyes associated with Sjögren's...
read more

Happy St. Patty’s day!

Current progress in Mark2Cure Thanks to our wonderful community of citizen scientists and volunteers, the NFE2L1 entity recognition mission is now 99% complete! If you haven’t already completed quests in this mission, please help us finish it! The other entity recognition missions are also over two thirds complete and are in need of your reading skills. If entity recognition is too easy, please...
read more